N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide

C44H57N7O6 — CID 163825286

IUPACN-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide
SMILESNc1nnc(-c2ccccc2O)cc1N1CCCC(CCCNC(=O)CCCCCCCCNc2cccc3c2C(=O)C(C2CCC(=O)NC2=O)CCC3=O)CC1
InChIInChI=1S/C44H57N7O6/c45-43-36(28-35(49-50-43)32-14-6-7-17-37(32)52)51-26-11-13-29(23-27-51)12-10-25-47-39(54)18-5-3-1-2-4-8-24-46-34-16-9-15-33-38(53)21-19-30(42(56)41(33)34)31-20-22-40(55)48-44(31)57/h6-7,9,14-17,28-31,46,52H,1-5,8,10-13,18-27H2,(H2,45,50)(H,47,54)(H,48,55,57)
InChIKeyNYXYSFRDLYXIBZ-UHFFFAOYSA-N
MW779.98 g/mol
LogP6.61
Rot. Bonds17

About N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide

N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide (PubChem CID 163825286) has the molecular formula C44H57N7O6 and a molecular weight of 779.98 g/mol. Its IUPAC name is N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide.

Molecular Properties

Compound NameN-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide
PubChem CID163825286
Molecular FormulaC44H57N7O6
Molecular Weight779.98 g/mol
Exact Mass779.44
IUPAC NameN-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide
SMILESNc1nnc(-c2ccccc2O)cc1N1CCCC(CCCNC(=O)CCCCCCCCNc2cccc3c2C(=O)C(C2CCC(=O)NC2=O)CCC3=O)CC1
InChIInChI=1S/C44H57N7O6/c45-43-36(28-35(49-50-43)32-14-6-7-17-37(32)52)51-26-11-13-29(23-27-51)12-10-25-47-39(54)18-5-3-1-2-4-8-24-46-34-16-9-15-33-38(53)21-19-30(42(56)41(33)34)31-20-22-40(55)48-44(31)57/h6-7,9,14-17,28-31,46,52H,1-5,8,10-13,18-27H2,(H2,45,50)(H,47,54)(H,48,55,57)
InChIKeyNYXYSFRDLYXIBZ-UHFFFAOYSA-N
XLogP6.61
TPSA196.71 Ų
H-Bond Donors5
H-Bond Acceptors11
Rotatable Bonds17
Heavy Atoms57
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500779.98
LogP ≤ 56.61
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide?
The IUPAC name of N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide (CID 163825286) is N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide.
What is the SMILES notation for N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide?
The canonical SMILES for N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide is Nc1nnc(-c2ccccc2O)cc1N1CCCC(CCCNC(=O)CCCCCCCCNc2cccc3c2C(=O)C(C2CCC(=O)NC2=O)CCC3=O)CC1.
What is the InChIKey of N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide?
The InChIKey is NYXYSFRDLYXIBZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H57N7O6/c45-43-36(28-35(49-50-43)32-14-6-7-17-37(32)52)51-26-11-13-29(23-27-51)12-10-25-47-39(54)18-5-3-1-2-4-8-24-46-34-16-9-15-33-38(53)21-19-30(42(56)41(33)34)31-20-22-40(55)48-44(31)57/h6-7,9,14-17,28-31,46,52H,1-5,8,10-13,18-27H2,(H2,45,50)(H,47,54)(H,48,55,57).
What are the key properties of N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide?
N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide has a molecular weight of 779.98 g/mol, XLogP of 6.61, 17 rotatable bonds, 5 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[1-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]azepan-4-yl]propyl]-9-[[6-(2,6-dioxopiperidin-3-yl)-5,9-dioxo-7,8-dihydro-6H-benzo[7]annulen-4-yl]amino]nonanamide is sourced from PubChem (CID 163825286), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).